BSE Live
Dec 12, 16:01Prev. Close
67.10
Open Price
67.66
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 12, 15:58Prev. Close
66.56
Open Price
67.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Valiant Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -1.45 | -0.75 | 38.14 | 41.70 | 47.02 | |
| Net CashFlow From Operating Activities | -21.90 | 48.78 | 22.96 | 2.25 | 9.11 | |
| Net Cash Used In Investing Activities | 24.97 | -182.73 | -21.18 | -12.24 | -16.67 | |
| Net Cash Used From Financing Activities | -0.50 | 135.80 | -1.53 | 6.18 | 11.43 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 2.57 | 1.85 | 0.25 | -3.81 | 3.87 | |
| Cash And Cash Equivalents Begin of Year | 2.23 | 0.38 | 0.13 | 3.94 | 0.07 | |
| Cash And Cash Equivalents End Of Year | 4.80 | 2.23 | 0.38 | 0.13 | 3.94 |
19.11.2025
Valiant Lab Consolidated September 2025 Net Sales at Rs 46.20 crore, up 115.1% Y-o-Y
12.11.2025
Valiant Lab Standalone September 2025 Net Sales at Rs 45.99 crore, up 114.11% Y-o-Y
22.08.2025
Valiant Lab Standalone June 2025 Net Sales at Rs 51.01 crore, up 170.11% Y-o-Y
22.05.2025
Valiant Lab Consolidated March 2025 Net Sales at Rs 57.79 crore, up 88.92% Y-o-Y
19.11.2025
Valiant Lab Consolidated September 2025 Net Sales at Rs 46.20 crore, up 115.1% Y-o-Y
12.11.2025
Valiant Lab Standalone September 2025 Net Sales at Rs 45.99 crore, up 114.11% Y-o-Y
22.08.2025
Valiant Lab Standalone June 2025 Net Sales at Rs 51.01 crore, up 170.11% Y-o-Y
22.05.2025
Valiant Lab Consolidated March 2025 Net Sales at Rs 57.79 crore, up 88.92% Y-o-Y